An outline of cancer chemotherapy.
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002478:Cells, Cultured; D003110:Colonic Neoplasms / Q000188:drug therapy; D006224:Cricetinae; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D006918:Hydroxyurea / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008937:Mitomycins / Q000627:therapeutic use; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D012334:RNA, Neoplasm / Q000096:biosynthesis; D051381:Rats; D012265:Ribonucleotides / Q000037:antagonists & inhibitors; D012270:Ribosomes / Q000378:metabolism; D014183:Transplantation, Heterologous
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D006834:Hydrazines; D008937:Mitomycins; D012334:RNA, Neoplasm; D012265:Ribonucleotides; D001215:Asparaginase; D006918:Hydroxyurea